What is Oscor?
Founded in 1982 and headquartered in Palm Harbor, Florida, Oscor has established itself as a critical player in the global healthcare supply chain. The company specializes in the design, manufacturing, and distribution of high-precision cardiac pacemaker components and advanced catheters. By maintaining a robust international presence, Oscor serves as a vital partner to medical institutions worldwide, ensuring the availability of essential life-saving hardware. Its market position is defined by decades of engineering expertise and a commitment to rigorous quality standards in the cardiovascular space.
How much funding has Oscor raised?
Oscor has raised a total of $147M across 2 funding rounds:
Unspecified
$145M
Debt
$2M
Unspecified (2015): $145M, investors not publicly disclosed
Debt (2020): $2M led by PPP
Key Investors in Oscor
PPP
Public-Private Partnership
Undisclosed Investor
A private capital partner participating in the strategic financing round to support long-term growth and market expansion.
What's next for Oscor?
With the recent infusion of capital, Oscor is positioned to accelerate its enterprise-level growth initiatives. The strategic allocation of these funds will likely focus on scaling production capacity for its core cardiac product lines and potentially expanding its research and development footprint to address emerging trends in minimally invasive surgery. As the company navigates the complexities of the global medical device market, this financial backing provides the necessary liquidity to pursue long-term infrastructure improvements and maintain its competitive edge against evolving industry standards.
See full Oscor company page
